Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Total 13F shares
-
37,941,245
-
Share change
-
+21,411,779
-
Total reported value
-
$819,531,685
-
Put/Call ratio
-
347%
-
Price per share
-
$21.60
-
Number of holders
-
105
-
Value change
-
+$470,945,810
-
Number of buys
-
93
-
Number of sells
-
12
Institutional Holders of LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (LBPH) as of Q1 2024
As of 31 Mar 2024,
LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (LBPH) was held by
105 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,941,245 shares.
The largest 10 holders included
FMR LLC, Cormorant Asset Management, LP, RA CAPITAL MANAGEMENT, L.P., FARALLON CAPITAL MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, Point72 Asset Management, L.P., and Polar Capital Holdings Plc.
This page lists
105
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.